SAN DIEGO, CA--(Marketwired - Jun 7, 2013) - Regen BioPharma, wholly owned subsidiary of Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN), announced today its submission of responses to the U.S. Food ...
Bio-Matrix Scientific Group Inc. has announced it has entered into a contract with Validation Systems, Inc. to complete and finalize its FDA Good Manufacturing Practices (cGMP) Quality Systems ...
SAN DIEGO--(BUSINESS WIRE)--Bio-Matrix Scientific Group, Inc. (OTCBB: BMSN) and Its majority owned subsidiary Entest BioMedical Inc. (OTCBB: ENTB) announced today they have finalized a definitive ...
SAN DIEGO, CA--(Marketwired - Oct 9, 2013) - Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) today announced that its Board of Directors has authorized a distribution on a pro rata basis as a dividend ...
SAN DIEGO, Oct. 4, 2010 (GLOBE NEWSWIRE) -- Bio-Matrix Scientific Group Inc. (OTCBB:BMSN) announced today the company has entered into discussions with several organizations regarding the ...
Matrix-Bio, Inc., a diagnostics company that uses metabolite profiling to detect cancer and other diseases, has signed an exclusive global licensing and marketing agreement for metabolomic biomarkers ...
WASHINGTON, Nov. 28, 2016 /PRNewswire/ — ACON Investments, L.L.C. and its affiliates (“ACON”) announced it has recently completed the purchase of BioMatrix Specialty Pharmacy, L.L.C. (“BioMatrix” or ...
Nexture Bio has acquired Matrix F.T. Nexture Bio plans to make its expanded portfolio of high-performing adherent cell culture products available to a global range of customers and partners, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback